FDA Reopens Comments on Over-the-Counter Antihistamine Drug Products for Common Cold Relief

Summary

The Food and Drug Administration (FDA) is reopening the administrative record for over-the-counter (OTC) antihistamine drug products to accept comments on its tentative position that these products can be used to relieve symptoms of sneezing and runny nose associated with the common cold, as discussed at a joint advisory committee meeting on November 16, 1995.